VTX-PID | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

8,417 results for “VTX-PID”

Trials

View all 6300 →

First-in-human study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of VTX-PID in healthy male volunteers

35 participants · First posted Sep 28, 2023

A Phase 1/2 Study of the Safety and Tolerability of ICM VTx-002 in participants with ALS

4 participants · First posted Mar 31, 2026

A Study to Evaluate Immune Biomarker Modulation in Response to VTX-2337 in Combination With an Anti- PD-1 Inhibitor in Head and Neck Cancer

15 participants · First posted Apr 8, 2019

Drugs

View all 1454 →

VTx-001

VTX-003

VTX-067

Organizations

View all 51 →

GTX INC

United States

GTx, Inc.

United States

VGX PHARMACEUTICALS, LLC

United States

News

View all 612 →

Lexeo to Acquire Mantle Therapeutics for Up to $21.3M, Adding Four Frataxin-Targeting FA Programs

VectorY Therapeutics Unveils Promising Preclinical Data for Novel ALS Treatment Targeting Oxidized Phospholipids

VectorY Therapeutics Appoints Jim Scibetta as CEO, Advances ALS Program

Page 1 of 842